Introduction: To evaluate incidence, symptoms and management of postoperative pancreatic fistula (POPF) after urologic surgery based on our experience. Material and Methods: Database was searched for clinically evident POPF after urologic surgery between 1998 and 2014. Fistulae were graded using the POPF classification. Clinical course of every POPF patient was evaluated. Results: During this time, 3,200 surgeries for renal, adrenal and retroperitoneal pathologies were performed. Twelve POPF occurred postoperatively in this series. Eight fistulae were POPF grade A, 3 POPF grade B and one POPF grade C. POPF became clinically evident after a median of 3 days (IQR 2-3). In all POPF grade A/B patients, secretion from the pancreatic fistula completely subsided under conservative therapy. In one POPF grade C patient with positive surgical margins of urothelial cancer, conservative treatment failed and the patient died due to POPF-related sepsis. Conclusions: POPF is a rare complication after urologic surgery. Conservative therapy is the first choice of treatment and will be successful in the majority of cases. Pancreatic fistula after surgery of recurrent malignancy may have a poor outcome.

Keywords:
Pancreatic fistula, Urologic surgery, Treatment algorithm
1.
Hackert T, Werner J, Büchler MW: Postoperative pancreatic fistula. Surgeon 2011;9:211-217.
2.
Bassi C, Dervenis C, Butturini G, et al: Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005;138:8-13.
3.
Varkarakis IM, Allaf ME, Bhayani SB, et al: Pancreatic injuries during laparoscopic urologic surgery. Urology 2004;65:1089-1093.
4.
Rassweiler J, Fornara P, Weber M, et al: Laparoscopic nephrectomy: the experience of the laparoscopy working group of the German urologic association. J Urol 1998;160:18-21.
5.
Liapis D, de la Taille A, Ploussard G, et al: Analysis of complications from 600 retroperitoneoscopic procedures of the upper urinary tract during the last 10 years. World J Urol 2008;26:523-530.
6.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
7.
Xu B, Wang JJ, Mi Y, Zhou LQ, Jin J, Zhang Q: Laparoscopic versus open partial nephrectomy for multilocular cystic renal cell carcinoma: a direct comparison based on single-center experience. Urol Int 2015;94:83-87.
8.
Daskalaki D, Butturini G, Molinari E, et al: A grading system can predict clinical and economic outcomes of pancreatic fistula after pancreaticoduodenectomy: results in 755 consecutive patients. Langenbecks Arch Surg 2011;396:91-98.
9.
Gurusamy KS, Koti R, Fusai G, et al: Somatostatin analogues for pancreatic surgery. Cochrane Database Syst Rev 2013;4:CD008370.
10.
Klek S, Sierzega M, Turczynowski L, et al: Enteral and parenteral nutrition in the conservative treatment of pancreatic fistula: a randomized clinical trial. Gastroenterology 2011;141:157-163.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.